FDA: Coffee Products Laced with Active Pharmaceutical Ingredients
Although these coffee products are labeled as a “natural” or “herbal” they can cause serious harm.
Angina
Non-Invasive ECG Device Gets FDA Clearance
Clinical data from the Turbulence study (n=1,807) showed CADence had comparable performance to a SPECT nuclear stress test in excluding obstructive CAD in patients with chest pain and risk factors.
Nitroglycerin Products Recalled Due to Low Potency
The products were distributed to healthcare facilities nationwide between March 9 and June 1 and have expiration dates ranging from June 6 to August 15, 2017.
NSAIDs May Up MI Risk Within the First Week of Use
Drug dose, duration of use, and recency of use were all evaluated.
FDA Fast Tracks Gene Therapy for Chronic Angina Patients
XC001 is an investigational cardiovascular angiogenic gene therapy that promotes angiogenesis to provide arterial blood flow to myocardial regions with inadequate blood supply.
How Metoprolol Helps Reduce Damage During Heart Attack
The data showed patients treated with metoprolol during acute myocardial infarction had a 40% reduced extent of microvascular obstruction.
High-Dose Vitamin D: Does It Prevent Cardiovascular Disease?
But effects of daily or weekly dosing require further study
Angina Prevention Medication Discontinued
The decision to stop manufacturing the product is business related.
Tool Helps Clinicians Determine When Tests Are Needed for Chest Pain
An online tool can accurately predict which patients with chest pain are likely to have normal non-invasive test results and remain free of cardiac adverse events.
Cardiovascular Angiogenic Gene Therapy Gets Fast Track Status
Angionetics has announced that its Phase 3 clinical investigation of Generx (Ad5FGF-4) has been granted Fast Track status by the Food and Drug Administration (FDA).
